Cargando…

Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)

OBJECTIVES: The aims of the Online Latin American Survey of Anaphylaxis (OLASA) were to identify the main clinical manifestations, triggers, and treatments of severe allergic reactions in patients who were seen by allergists from July 2008 to June 2010 in 15 Latin American countries and Portugal (n ...

Descripción completa

Detalles Bibliográficos
Autores principales: Solé, Dirceu, Ivancevich, Juan Carlos, Borges, Mario Sánchez, Coelho, Magna Adaci, Rosário, Nelson A, Ardusso, Ledit Ramón Francisco, Bernd, Luis Antônio Guerra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129950/
https://www.ncbi.nlm.nih.gov/pubmed/21808856
http://dx.doi.org/10.1590/S1807-59322011000600004
_version_ 1782207565494484992
author Solé, Dirceu
Ivancevich, Juan Carlos
Borges, Mario Sánchez
Coelho, Magna Adaci
Rosário, Nelson A
Ardusso, Ledit Ramón Francisco
Bernd, Luis Antônio Guerra
author_facet Solé, Dirceu
Ivancevich, Juan Carlos
Borges, Mario Sánchez
Coelho, Magna Adaci
Rosário, Nelson A
Ardusso, Ledit Ramón Francisco
Bernd, Luis Antônio Guerra
author_sort Solé, Dirceu
collection PubMed
description OBJECTIVES: The aims of the Online Latin American Survey of Anaphylaxis (OLASA) were to identify the main clinical manifestations, triggers, and treatments of severe allergic reactions in patients who were seen by allergists from July 2008 to June 2010 in 15 Latin American countries and Portugal (n = 634). RESULTS: Of all patients, 68.5% were older than 18 years, 41.6% were male, and 65.4% experienced the allergic reaction at home. The etiologic agent was identified in 87.4% of cases and predominantly consisted of drugs (31.2%), foods (23.3%), and insect stings (14.9%). The main symptom categories observed during the acute episodes were cutaneous (94.0%) and respiratory (79.0%). The majority of patients (71.6%) were treated initially by a physician (office/emergency room) within the first hour after the reaction occurred (60.2%), and 43.5% recovered in the first hour after treatment. Most patients were treated in an emergency setting, but only 37.3% received parenteral epinephrine alone or associated with other medication. However, 80.5% and 70.2% were treated with corticosteroids or antihistamines (alone or in association), respectively. A total of 12.9% of the patients underwent reanimation maneuvers, and 15.2% were hospitalized. Only 5.8% of the patients returned to the emergency room after discharge, with 21.7% returning in the first 6 hours after initial treatment. CONCLUSION: The main clinical manifestations of severe allergic reactions were cutaneous. The etiologic agents that were identified as causing these acute episodes differed according to age group. Following in order: drugs (31.2%), foods (23.3% and insect stings (14.9%) in adults with foods predominance in children. Treatment provided for acute anaphylactic reactions was not appropriate. It is necessary to improve educational programs in order to enhance the knowledge on this potentially fatal emergency.
format Online
Article
Text
id pubmed-3129950
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-31299502011-07-06 Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA) Solé, Dirceu Ivancevich, Juan Carlos Borges, Mario Sánchez Coelho, Magna Adaci Rosário, Nelson A Ardusso, Ledit Ramón Francisco Bernd, Luis Antônio Guerra Clinics (Sao Paulo) Clinical Science OBJECTIVES: The aims of the Online Latin American Survey of Anaphylaxis (OLASA) were to identify the main clinical manifestations, triggers, and treatments of severe allergic reactions in patients who were seen by allergists from July 2008 to June 2010 in 15 Latin American countries and Portugal (n = 634). RESULTS: Of all patients, 68.5% were older than 18 years, 41.6% were male, and 65.4% experienced the allergic reaction at home. The etiologic agent was identified in 87.4% of cases and predominantly consisted of drugs (31.2%), foods (23.3%), and insect stings (14.9%). The main symptom categories observed during the acute episodes were cutaneous (94.0%) and respiratory (79.0%). The majority of patients (71.6%) were treated initially by a physician (office/emergency room) within the first hour after the reaction occurred (60.2%), and 43.5% recovered in the first hour after treatment. Most patients were treated in an emergency setting, but only 37.3% received parenteral epinephrine alone or associated with other medication. However, 80.5% and 70.2% were treated with corticosteroids or antihistamines (alone or in association), respectively. A total of 12.9% of the patients underwent reanimation maneuvers, and 15.2% were hospitalized. Only 5.8% of the patients returned to the emergency room after discharge, with 21.7% returning in the first 6 hours after initial treatment. CONCLUSION: The main clinical manifestations of severe allergic reactions were cutaneous. The etiologic agents that were identified as causing these acute episodes differed according to age group. Following in order: drugs (31.2%), foods (23.3% and insect stings (14.9%) in adults with foods predominance in children. Treatment provided for acute anaphylactic reactions was not appropriate. It is necessary to improve educational programs in order to enhance the knowledge on this potentially fatal emergency. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011-06 /pmc/articles/PMC3129950/ /pubmed/21808856 http://dx.doi.org/10.1590/S1807-59322011000600004 Text en Copyright © 2011 Hospital das Clínicas da FMUSP http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
Solé, Dirceu
Ivancevich, Juan Carlos
Borges, Mario Sánchez
Coelho, Magna Adaci
Rosário, Nelson A
Ardusso, Ledit Ramón Francisco
Bernd, Luis Antônio Guerra
Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)
title Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)
title_full Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)
title_fullStr Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)
title_full_unstemmed Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)
title_short Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)
title_sort anaphylaxis in latin america: a report of the online latin american survey on anaphylaxis (olasa)
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129950/
https://www.ncbi.nlm.nih.gov/pubmed/21808856
http://dx.doi.org/10.1590/S1807-59322011000600004
work_keys_str_mv AT soledirceu anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT ivancevichjuancarlos anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT borgesmariosanchez anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT coelhomagnaadaci anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT rosarionelsona anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT ardussoleditramonfrancisco anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT berndluisantonioguerra anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa
AT anaphylaxisinlatinamericaareportoftheonlinelatinamericansurveyonanaphylaxisolasa